The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Anthim Market In 2026 And How Much Will It Reach By 2030?
The size of the anthim market has seen significant growth over the past few years. This market is anticipated to expand, moving from $4.3 million in 2025 to reach $4.63 million by 2026, achieving a compound annual growth rate (CAGR) of 7.6%. Historically, this expansion has been driven by bioterrorism preparedness initiatives, government funding directed towards biodefense, the proven efficacy of monoclonal antibody therapies, strategic national stockpile programs, and regulatory approvals issued for emergency use.
The anthim market is projected to experience robust expansion over the coming years. This market is anticipated to reach a valuation of **$6.13 million by 2030**, driven by a **compound annual growth rate (CAGR) of 7.3%**. The expansion throughout the projected period can be attributed to ongoing investments in biodefense, an increased emphasis on pandemic and biosecurity preparedness, the broadening of emergency response infrastructure, advancements in antibody production technology, and extended government procurement agreements. Key trends during this forecast period encompass greater stockpiling of anthrax countermeasures, the development of more government preparedness initiatives, an escalating application of monoclonal antibodies in biodefense, the broadening of emergency response treatment guidelines, and a heightened focus on therapies for swift deployment.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19875&type=smp
Which Significant Factors Are Encouraging Growth In The Anthim Market?
The anthim market is anticipated to expand due to the increasing incidence of bacterial infections. These infections are illnesses resulting from harmful bacteria invading and multiplying within the body, releasing toxins. The escalation of bacterial infections is attributed to factors such as excessive antibiotic use, international travel, urban expansion, inadequate hygiene, and infections acquired in healthcare settings. Anthim (obiltoxaximab) specifically targets anthrax, a bacterial infection caused by Bacillus anthracis, by counteracting the anthrax toxin and stopping it from entering cells, thereby lessening its damaging effects. For example, a World Health Organization (WHO) report from Switzerland, published in December 2023, indicated a significant increase in suspected anthrax cases in Zambia, rising from 42 between September 2022 and January 2023 to 684 by November 20, 2023. This included four fatalities (0.6% CFR) and affected 44 districts across nine out of the country’s ten provinces. Consequently, the rising prevalence of bacterial infections is a primary catalyst for the growth of the anthim market.
Which Segment Divisions Form The Structure Of The Anthim Market?
The anthim market covered in this report is segmented –
1) By Type: Adult, Children
2) By Clinical Indications: Inhalational Anthrax Treatment, Post-Exposure Prophylaxis (PEP) For Inhalational Anthrax, Use In Pediatric And Adult Populations
3) By Application: Hospital, Drugs Store, Other Applications
Who Are The Key Market Participants In The Anthim Market?
Major companies operating in the anthim market are Elusys Therapeutics Inc, Hikma Pharmaceuticals
Access The Complete Anthim Market Report:
https://www.thebusinessresearchcompany.com/report/anthim-global-market-report
Which Geographic Region Represents The Largest Anthim Market Share?
North America was the largest region in the anthim market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthim market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model